A non-bioabsorbable, implantable device intended to induce a thrombosis within a non-neurovascular blood vessel to treat an aneurysm and/or non-neurovascular arteriovenous malformation (AVM); it is not intended for neurovascular application. It is in the form
| Company | Devices | Share |
|---|---|---|
| Cook Incorporated | 477 | 24% |
| Balt Usa Llc | 457 | 23% |
| Microvention, Inc. | 245 | 12% |
| Penumbra, Inc. | 221 | 11% |
| Micro Therapeutics, Inc. | 220 | 11% |
| Boston Scientific Corporation | 151 | 8% |
| Stryker Corporation | 101 | 5% |
| Kaneka Corporation | 53 | 3% |
| Medtronic, Inc. | 53 | 3% |
| William Cook Europe Aps | 12 | 1% |
| Embolization Inc. | 5 | 0% |
Company = labeler of record on GUDID. 11 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| KRD | Device, Vascular, for Promoting Embolization | 1,297 |
| KRD | Device, Vascular, For Promoting Embolization | 653 |
| HCG | DEVICE, NEUROVASCULAR EMBOLIZATION | 390 |
| HCG | Device, Neurovascular Embolization | 70 |
Use these as the dimensions to specify in a tender line.
1,995 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Non-neurovascular embolization coil", from 11 companies. The largest labeler is Cook Incorporated with 24% of records.
KRD (Device, Vascular, for Promoting Embolization), KRD (Device, Vascular, For Promoting Embolization), HCG (DEVICE, NEUROVASCULAR EMBOLIZATION), HCG (Device, Neurovascular Embolization)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add non-neurovascular embolization coil to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.